Inlyta Approved in Treatment of Advanced Kidney Cancer
New Drugs , News / September 28, 2016

The FDA approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to other drugs for this type of cancer. Renal cell carcinoma is a type of kidney cancer that starts in the lining of ver...

Skip to toolbar